Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker NUVB
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | Gary Hattersley CHIEF SCIENTIFIC OFFICER | NUVB Nuvation Bio Inc. | Sale | 100,000 | $7.09 | $709.0K Sale | Form 4 ↗ |
| Jun 23, 2026 | Philippe Sauvage Chief Financial Officer | NUVB Nuvation Bio Inc. | Sale | 47,668 | $6.01 | $286.5K Sale | Form 4 ↗ |
| Jun 23, 2026 | Stacy Markel CHIEF PEOPLE OFFICER | NUVB Nuvation Bio Inc. | Sale | 125,000 | $6.03 | $753.8K Sale | Form 4 ↗ |
| Jun 23, 2026 | Kerry Wentworth CHIEF REGULATORY OFFICER | NUVB Nuvation Bio Inc. | Sale | 63,000 | $6.02 | $379.3K Sale | Form 4 ↗ |
| Jun 9, 2026 | Robert Mashal Director | NUVB Nuvation Bio Inc. | Buy | 25,000 | $4.73 | $118.3K Buy | Form 4 ↗ |
| Apr 17, 2026 | Dongfang Liu CHIEF MEDICAL OFFICER | NUVB Nuvation Bio Inc. | Sale | 50,000 | $5.02 | $251.0K Sale | Form 4 ↗ |
| Apr 17, 2026 | Kerry Wentworth CHIEF REGULATORY OFFICER | NUVB Nuvation Bio Inc. | Sale | 36,750 | $5.01 | $184.1K Sale | Form 4 ↗ |
| Apr 6, 2026 | Kerry Wentworth CHIEF REGULATORY OFFICER | NUVB Nuvation Bio Inc. | Sale | 200,000 | $4.52 | $904.0K Sale | Form 4 ↗ |
| Dec 1, 2025 | Dongfang Liu CHIEF MEDICAL OFFICER | NUVB Nuvation Bio Inc. | Sale | 150,000 | $7.82 | $1.2M Sale | Form 4 ↗ |
| Nov 26, 2025 | Dongfang Liu CHIEF MEDICAL OFFICER | NUVB Nuvation Bio Inc. | Sale | 10,000 | $8.00 | $80.0K Sale | Form 4 ↗ |
| Nov 25, 2025 | Dongfang Liu CHIEF MEDICAL OFFICER | NUVB Nuvation Bio Inc. | Sale | 10,000 | $7.50 | $75.0K Sale | Form 4 ↗ |
| Nov 20, 2025 | Dongfang Liu CHIEF MEDICAL OFFICER | NUVB Nuvation Bio Inc. | Sale | 20,000 | $7.00 | $140.0K Sale | Form 4 ↗ |
| Nov 20, 2025 | Gary Hattersley CHIEF SCIENTIFIC OFFICER | NUVB Nuvation Bio Inc. | Sale | 300,000 | $7.23 | $2.2M Sale | Form 4 ↗ |
| Nov 20, 2025 | Gary Hattersley CHIEF SCIENTIFIC OFFICER | NUVB Nuvation Bio Inc. | Sale | 69,051 | $7.23 | $499.2K Sale | Form 4 ↗ |
| Nov 19, 2025 | Dongfang Liu CHIEF MEDICAL OFFICER | NUVB Nuvation Bio Inc. | Sale | 15,000 | $5.10 | $76.5K Sale | Form 4 ↗ |
| Nov 19, 2025 | David C. Hanley CHIEF TECHNICAL OPERATIONS | NUVB Nuvation Bio Inc. | Sale | 200,000 | $7.14 | $1.4M Sale | Form 4 ↗ |
| Nov 17, 2025 | Dongfang Liu CHIEF MEDICAL OFFICER | NUVB Nuvation Bio Inc. | Sale | 15,000 | $4.77 | $71.5K Sale | Form 4 ↗ |
| Oct 27, 2025 | Gary Hattersley CHIEF SCIENTIFIC OFFICER | NUVB Nuvation Bio Inc. | Sale | 100,000 | $5.02 | $502.0K Sale | Form 4 ↗ |
| Jun 18, 2025 | Stacy Markel CHIEF PEOPLE OFFICER | NUVB Nuvation Bio Inc. | Buy | 10,000 | $1.71 | $17.1K Buy | Form 4 ↗ |
| Jun 17, 2025 | Philippe Sauvage Chief Financial Officer | NUVB Nuvation Bio Inc. | Buy | 4,000 | $1.79 | $7,160 Buy | Form 4 ↗ |
| Jun 16, 2025 | Philippe Sauvage Chief Financial Officer | NUVB Nuvation Bio Inc. | Buy | 3,300 | $1.84 | $6,072 Buy | Form 4 ↗ |
| Jun 16, 2025 | Colleen Sjogren Chief Commercial Officer | NUVB Nuvation Bio Inc. | Buy | 50,000 | $1.81 | $90.5K Buy | Form 4 ↗ |
| Jun 16, 2025 | Kerry Wentworth CHIEF REGULATORY OFFICER | NUVB Nuvation Bio Inc. | Buy | 24,000 | $1.80 | $43.2K Buy | Form 4 ↗ |
| Jun 16, 2025 | Kerry Wentworth CHIEF REGULATORY OFFICER | NUVB Nuvation Bio Inc. | Buy | 26,000 | $1.79 | $46.5K Buy | Form 4 ↗ |
| Jun 16, 2025 | David Hung PRESIDENT AND CEO, Director, 10% owner | NUVB Nuvation Bio Inc. | Buy | 500,000 | $1.79 | $895.0K Buy | Form 4 ↗ |
| May 2, 2025 | Dongfang Liu CHIEF MEDICAL OFFICER | NUVB Nuvation Bio Inc. | Sale | 20,000 | $2.50 | $50.0K Sale | Form 4 ↗ |
| Apr 7, 2025 | David Hung PRESIDENT AND CEO, Director, 10% owner | NUVB Nuvation Bio Inc. | Buy | 300,000 | $1.63 | $489.0K Buy | Form 4 ↗ |
| Apr 4, 2025 | David Hung PRESIDENT AND CEO, Director, 10% owner | NUVB Nuvation Bio Inc. | Buy | 200,000 | $1.66 | $332.0K Buy | Form 4 ↗ |
| Apr 1, 2025 | Robert Mashal Director | NUVB Nuvation Bio Inc. | Buy | 98,900 | $1.67 | $165.2K Buy | Form 4 ↗ |
| Apr 1, 2025 | Robert Mashal Director | NUVB Nuvation Bio Inc. | Buy | 1,100 | $1.67 | $1,837 Buy | Form 4 ↗ |
| Nov 11, 2024 | Junyuan Jerry Wang CEO, ANHEART THERAPEUTICS LTD., Director | NUVB Nuvation Bio Inc. | Sale | 56,361 | $2.89 | $162.9K Sale | Form 4 ↗ |
| Oct 8, 2024 | Robert Mashal Director | NUVB Nuvation Bio Inc. | Buy | 99,981 | $2.20 | $220.0K Buy | Form 4 ↗ |
| Oct 8, 2024 | Robert Mashal Director | NUVB Nuvation Bio Inc. | Buy | 19 | $2.20 | $41.8 Buy | Form 4 ↗ |
33 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:48 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances